Myocardial Ischaemic Syndromes: Shifting from a Coronary-centric to a Substrate-based Nomenclature is More Accurate
William E Boden1,2, Juan Carlos Kaski3, C Noel Bairey Merz4
1VA Boston Healthcare System Boston, MA, US.
Insights
A new classification for myocardial ischaemic syndromes is proposed, moving beyond just epicardial coronary lesions to include non-obstructive causes. This substrate-based approach offers a more accurate, patient-centric view of ischaemia.
Area of Science:
- Cardiology
- Medical Classification Systems
Background:
- Current angina and myocardial ischaemia classifications focus heavily on epicardial coronary lesions.
- This vessel-based approach overlooks non-obstructive causes and 'silent' ischaemia, particularly in patients with microvascular dysfunction like those with diabetes.
Purpose of the Study:
- To advocate for a more accurate and inclusive classification of ischaemic syndromes.
- To propose a shift from a vessel-based to a substrate-based nomenclature.
Main Methods:
- Review and critique of existing classification systems for angina and myocardial ischaemia.
- Conceptual development of a new 'substrate-based' classification.
Main Results:
- The current classification is overly simplistic and restrictive, failing to encompass all causes of ischaemia.
- A substrate-based nomenclature, including both obstructive and non-obstructive causes, is presented as a superior alternative.
Conclusions:
- A new classification for myocardial ischaemic syndromes is needed to better represent the full spectrum of pathophysiologic causes.
- The proposed substrate-based approach promotes a unified, patient-centric understanding of ischaemia, encompassing both epicardial and non-epicardial aetiologies.
Abstract:
This article highlights the rationale for a more accurate and inclusive classification that does not focus solely on epicardial coronary lesions as the causa sine qua non for angina and myocardial ischaemia in all patients but rather represents a more comprehensive classification encompassing both obstructive and non-obstructive causes. Ischaemia may be 'silent' clinically or electrocardiographically and is observed in both acute and non-acute settings, as seen in patients with diabetes and other conditions associated with microvascular dysfunction. By pivoting away from the more restrictive and overly simplistic 'vessel-based' classification that disproportionately focuses on obstructed epicardial arteries to a 'substrate-based' nomenclature inclusive of both obstructive and non-obstructive causes, 'myocardial ischaemic syndromes' will better align and unify a patient-centric approach by harmonising the full spectrum of pathophysiologic causes.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy I: Introduction and Classification


